Liver Cancer Treatment Drugs and Metastasis Control

liver cancer treatment Hepatocellular Carcinoma (HCC) There are several options available, depending on the stage of the disease and the patient's health. One of them is the use of drugs to control and inhibit the growth of cancer cells.

1. Medicine to treat early and middle stage liver cancer

Sorafenib (Nexavar): a targeted therapy of the Tyrosine Kinase Inhibitor (TKI) family that inhibits the growth of cancer cells.
Lenvatinib (Lenvima): Another TKI used to treat early-to-mid stage liver cancer, often used in place of Sorafenib.
TACE (Transarterial Chemoembolization): Chemotherapy injection: into the arteries that feed the tumor. It may be used in conjunction with Targeted Therapy drugs.

2. Drugs to treat advanced stage liver cancer

Atezolizumab + Bevacizumab: is a treatment for Immunotherapy combined with Anti-VEGF drugs that reduce the growth of new blood vessels that feed cancer cells.
Cabozantinib (Cabometyx): This is a TKI that can be used to treat liver cancer that is advanced and resistant to other treatments.
Regorafenib (Stivarga): used to treat patients who respond to Sorafenib but whose disease continues to progress.
Ramucirumab (Cyramza): Used in patients with elevated AFP in combination with other targeted therapy.

3. Complementary treatments and new approaches

Other types of immunotherapy: such as Pembrolizumab It may be used in some cases that are resistant to other treatments.
Combination Medicine: Use of Targeted Therapy with Immunotherapy tends to give better results

The choice of medication to treat liver cancer depends on the stage of the disease. and health of patients There are drugs in both Targeted Therapy and Immunotherapy. and specific treatments such as TACE, where the doctor will consider the appropriate approach for each individual.